Your search returned 3 results.

Results
	1.	Selective inhibitors of aurora kinases inhibit proliferation, reduce cell viability and impair cell cycle progression in papillary thyroid carcinoma cells. [electronic resource] by Baldini, E Tuccilli, C Prinzi, N Sorrenti, S Antonelli, A Fallahi, P Mian, C Barollo, S Catania, A Morrone, S Tartaglia, F Mascagni, D Coccaro, C Pepe, M Filippini, A D'Armiento, M Ulisse, S Producer: 20160303 In: Journal of biological regulators and homeostatic agents vol. 29 Availability: No items available. Save to lists Add to cart (remove)
	2.	The dual Aurora kinase inhibitor ZM447439 prevents anaplastic thyroid cancer cell growth and tumorigenicity. [electronic resource] by Baldini, E Tuccilli, C Prinzi, N Sorrenti, S Antonelli, A Gnessi, L Catania, A Moretti, C Mocini, R Carbotta, G Morrone, S Persechino, S Redler, A De Antoni, E D' Armiento, M Ulisse, S Producer: 20131127 In: Journal of biological regulators and homeostatic agents vol. 27 Availability: No items available. Save to lists Add to cart (remove)
	3.	PAPILLARY THYROID CANCER IS CHARACTERIZED BY ALTERED EXPRESSION OF GENES INVOLVED IN THE SUMOYLATION PROCESS. [electronic resource] by Tuccilli, C Baldini, E Sorrenti, S Di Gioia, C Bosco, D Ascoli, V Mian, C Barollo, S Rendina, R Coccaro, C Pepe, M Catania, A Bononi, M Tartaglia, F De Antoni, E D'Armiento, M Ulisse, S Producer: 20151116 In: Journal of biological regulators and homeostatic agents vol. 29 Availability: No items available. Save to lists Add to cart (remove)